Novolilly Pharmaceutical Private Limited

Pharmaceutical company manufacturing and trading various medicines, with a wide brand portfolio and global distribution network.

2021 | Panchkula, Haryana (India) | Active
Last Updated:

Novolilly Pharmaceutical Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 378.37%
  • Profit Growth 60.78%
  • Ebitda 49.03%
  • Net Worth -42.41%
  • Total Assets 42.69%

About Novolilly Pharmaceutical

Novolilly Pharmaceutical Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 June 2021 (Three years and 11 months 6 days old ). Its registered office is in Panchkula, Haryana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Vaneet Jain, Navneet Bansal, and Gomeda Bansal serve as directors at the Company.

Company Details

  • Location

    Panchkula, Haryana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24299HR2021PTC095493

  • Company No.

    095493

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    08 Jun 2021

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Novolilly Pharmaceutical Private Limited offer?

Novolilly Pharmaceutical Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Malaria Medicine, Antibacterial Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Pharmaceutical Medicine, Skin Ointment.

Company report

Novolilly Pharmaceutical Private Limited

Explore comprehensive data for Novolilly Pharmaceutical Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Novolilly Pharmaceutical?

Board Members (3)

NameDesignationAppointment DateStatus
Vaneet Jain Country flag representing In Director 08-Jun-2021Current
Navneet Bansal Country flag representing In Director 08-Jun-2021Current
Gomeda Bansal Country flag representing In Additional Director 08-Jan-2022Current

Financial Performance of Novolilly Pharmaceutical.

Novolilly Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 378.37% increase. The company also saw a substantial improvement in profitability, with a 60.78% increase in profit. The company's net worth observed a substantial decline by a decrease of 42.41%.

Novolilly Pharmaceutical revenue growth over time
Novolilly Pharmaceutical profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
378.37%
Revenue from Operations
381.41%
Total Assets
42.69%
Profit or Loss
60.78%
Net Worth
-42.41%
EBITDA
49.03%

What is the Ownership and Shareholding Structure of Novolilly Pharmaceutical?

Unlock access to Novolilly Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Novolilly Pharmaceutical?

Novolilly Pharmaceutical has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Novolilly Pharmaceutical Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novolilly Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novolilly Pharmaceutical's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Novolilly Pharmaceutical

Recent activity within the organization

  • Annual General Meeting

    Novolilly Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Novolilly Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Director Appointment

    Gomeda Bansal was appointed as a Additional Director was appointed as a Additional Director on 08 Jan 2022 & has been associated with this company since 3 years 4 months .

  • Director Appointment

    Vaneet Jain was appointed as a Director was appointed as a Director on 08 Jun 2021 & has been associated with this company since 3 years 11 months .

  • Director Appointment

    Navneet Bansal was appointed as a Director was appointed as a Director on 08 Jun 2021 & has been associated with this company since 3 years 11 months .

  • Company Incorporation

    Novolilly Pharmaceutical Private Limited was registered on 08 Jun 2021 with Roc Delhi & aged 3 years 11 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Novolilly Pharmaceutical Private Limited?

    Novolilly Pharmaceutical Private Limited was incorporated on 08 Jun 2021.

  • What is authorized share capital and paid-up capital of Novolilly Pharmaceutical Private Limited?

    The authorized share capital of Novolilly Pharmaceutical Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Novolilly Pharmaceutical Private Limited?

    Currently 3 directors are associated with Novolilly Pharmaceutical Private Limited.

    • Vaneet Jain
    • Navneet Bansal
    • Gomeda Bansal

  • What is the registered address of Novolilly Pharmaceutical Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Novolilly Pharmaceutical Private Limited is House No.590, Sector 4 Urban Estate India, Panchkula, Haryana, 134112.

  • What is the corporate identification number (CIN) and company number of Novolilly Pharmaceutical Private Limited?

    The corporate identification number (CIN) of Novolilly Pharmaceutical Private Limited is U24299HR2021PTC095493 and the company number is 095493 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Novolilly Pharmaceutical Private Limited?

    The Official website of Novolilly Pharmaceutical Private Limited is https://www.novolillypharma.com

  • What has been the recent revenue trend for Novolilly Pharmaceutical Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Novolilly Pharmaceutical Private Limited has risen by 378.37%.

  • What change has been observed in the net worth of Novolilly Pharmaceutical Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Novolilly Pharmaceutical Private Limited has experienced an downturn of -42.41%.

  • When was the last Balance Sheet of Novolilly Pharmaceutical Private Limited filed with the ROC?

    The most recent Balance Sheet for Novolilly Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development